Our Portfolio


New This Month – Projects Funded in Partnership with LLS and PAFG

Loss of the Non-Canonical BAF Complex as a Driver and Therapeutic Target in SF3B1-Mutant MDS and Leukemia

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Robert Bradley, PhD, Fred Hutchinson Cancer Research Center

Read More

Targeting Leukemia Stem Cells by Disrupting Translational Fidelity

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Robert Signer, PhD, University of California San Diego

Read More

Clonal Evolution of Pre-Leukemic Hematopoietic Stem Cells in Human Myeloid Malignancies

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Ravi Majeti, MD, PhD, Stanford University School of Medicine

Read More

Mechanisms of Tumor-Initiation in B-Lymphoid Malignancies

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Markus Müschen, MD, PhD, City of Hope

Read More

In Vivo Generation of Chimeric Antigen Receptor Cells to Treat Hemopoietic Malignancies

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Ron Levy, MD, Stanford University School of Medicine

Read More

Detection and Targeting of Enzymatic Base Editing Deregulation in Leukemia Stem Cells

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Catriona Jamieson, MD, PhD, University of California San Diego

Read More

The Cellular and Architectural Determinants of Immune Evasion and Their Impact on Response to Therapy in Classical Hodgkin Lymphoma

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Margaret A. Shipp, MD, Dana-Farber Cancer Institute/ Harvard Medical School

Read More

T Cell Acute Lymphoblastic Leukemia Accumulation in the Central Nervous System

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Susan R. Schwab, PhD, New York University

Read More

Rational Therapeutic Targeting of Oncogenic Immune Signaling States in Myeloid Malignancies

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Daniel T. Starczynowski, PhD, Cincinnati Children's Research Foundation

Read More


All Projects

filter by

Program

Research Area

Cancer Types

Show All

Cysteine-Modification Screening to Identify Functional and Druggable Sites in Cancer Dependencies

Damon Runyon - Mark Foundation Postdoctoral Fellow (2020-Present)

Haoxin Li, PhD, The Scripps Research Institute

Read More

Uncovering the Mystery of Metastatic Dormancy in Breast Cancer: An Unprecedented View

ASPIRE Award (2020-Present)

Alana Welm, PhD, University of Utah

Read More

Elucidating the Mechanism of Menin-MLL Interaction Inhibition in NPM1c Mutated Acute Myeloid Leukemia

Momentum Fellow (2020-Present)

Hannah Uckelmann, PhD, Dana-Farber Cancer Institute

Read More

Development and Application of a Pan-Cancer Diagnostic Test for Early Detection of Cancer

Momentum Fellow (2020-Present)

Dimitrios Mathios MD, Johns Hopkins University School of Medicine

Read More

Characterizing a Novel RasGRP1-mTOR Pathway in Immune and Cancer Cells

Momentum Fellow (2020-Present)

Kriti Bahl, PhD, University of California, San Francisco

Read More

Dissecting Tumor Intrinsic and Immune Drivers of Resistance to Therapy in Non-Small Cell Lung Cancer

Damon Runyon - Mark Foundation Physician-Scientist (2020-Present)

Natalie Vokes, MD, Dana-Farber Cancer Institute

Read More

Statistical Approaches for Earlier Detection of Cancer

Momentum Fellow (2020-Present)

Stephen Cristiano, PhD, Johns Hopkins University School of Medicine

Read More

Impact of Clonal Hematopoiesis on the Myeloid Gene Regulatory Networks that Modulate Cancer Evolution and Response to Therapy

Momentum Fellow (2020-Present)

Pablo Sánchez Vela, MD, Memorial Sloan Kettering Cancer Center

Read More

A Liquid Biopsy Test for the Early Detection of High-Risk Colorectal Adenomas

ASPIRE Award (2020-Present)

Dan Landau, MD, PhD, Weill Cornell School of Medicine (Principal) and Claus Andersen, PhD, Aarhus University

Read More

Blood-Based Cancer Screening for Lynch Syndrome Patients

ASPIRE AWARD (2020-Present)

Michael Berger, PhD, Memorial Sloan Kettering Cancer Center

Read More